Integral Diagnostics Ltd. (AU:IDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Capitol Health Limited has received Federal Court approval for its merger with Integral Diagnostics Limited, set to become legally effective on December 11, 2024. Following this, Capitol’s shares will be suspended from trading on the ASX, and new Integral Diagnostics shares will begin trading on December 12, 2024. The merger aims to enhance diagnostic imaging services across Australia.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.